SK146293A3 - Cefalosporine salts and method of their production - Google Patents
Cefalosporine salts and method of their production Download PDFInfo
- Publication number
- SK146293A3 SK146293A3 SK1462-93A SK146293A SK146293A3 SK 146293 A3 SK146293 A3 SK 146293A3 SK 146293 A SK146293 A SK 146293A SK 146293 A3 SK146293 A3 SK 146293A3
- Authority
- SK
- Slovakia
- Prior art keywords
- salt
- cephalosporin
- articaine
- cefotaxime
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4244069A DE4244069A1 (de) | 1992-12-24 | 1992-12-24 | Cephalosporinsalze und Verfahren zu deren Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK146293A3 true SK146293A3 (en) | 1994-12-07 |
Family
ID=6476531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1462-93A SK146293A3 (en) | 1992-12-24 | 1993-12-22 | Cefalosporine salts and method of their production |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0603755A3 (sl) |
| JP (1) | JPH06247974A (sl) |
| KR (1) | KR940014406A (sl) |
| CN (1) | CN1093089A (sl) |
| AU (1) | AU672056B2 (sl) |
| BR (1) | BR9305213A (sl) |
| CA (1) | CA2112196A1 (sl) |
| CZ (1) | CZ285693A3 (sl) |
| DE (1) | DE4244069A1 (sl) |
| EC (1) | ECSP930947A (sl) |
| FI (1) | FI935797A (sl) |
| HR (1) | HRP931517A2 (sl) |
| HU (1) | HUT66141A (sl) |
| IL (1) | IL108134A0 (sl) |
| MA (1) | MA23070A1 (sl) |
| MX (1) | MX9308061A (sl) |
| NO (1) | NO934791L (sl) |
| NZ (1) | NZ250547A (sl) |
| OA (1) | OA09846A (sl) |
| PL (1) | PL301623A1 (sl) |
| SI (1) | SI9300685A (sl) |
| SK (1) | SK146293A3 (sl) |
| TN (1) | TNSN93138A1 (sl) |
| TW (1) | TW353662B (sl) |
| UY (1) | UY23683A1 (sl) |
| YU (1) | YU80593A (sl) |
| ZA (1) | ZA939609B (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1401825E (pt) | 2001-06-11 | 2009-10-23 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus |
| US8329924B2 (en) | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643325B2 (de) * | 1967-07-07 | 1976-05-06 | Hoechst Ag, 6000 Frankfurt | 3-aminoacylaminothiophene und verfahren zu ihrer herstellung |
-
1992
- 1992-12-24 DE DE4244069A patent/DE4244069A1/de not_active Withdrawn
-
1993
- 1993-06-28 EC EC1993000947A patent/ECSP930947A/es unknown
- 1993-09-17 TW TW082107623A patent/TW353662B/zh active
- 1993-12-09 UY UY23683A patent/UY23683A1/es unknown
- 1993-12-16 MX MX9308061A patent/MX9308061A/es unknown
- 1993-12-17 EP EP9393120375A patent/EP0603755A3/en not_active Withdrawn
- 1993-12-21 CZ CZ932856A patent/CZ285693A3/cs unknown
- 1993-12-22 NZ NZ250547A patent/NZ250547A/en unknown
- 1993-12-22 AU AU52667/93A patent/AU672056B2/en not_active Ceased
- 1993-12-22 FI FI935797A patent/FI935797A/fi not_active Application Discontinuation
- 1993-12-22 YU YU80593A patent/YU80593A/sh unknown
- 1993-12-22 IL IL10813493A patent/IL108134A0/xx unknown
- 1993-12-22 JP JP5323921A patent/JPH06247974A/ja active Pending
- 1993-12-22 ZA ZA939609A patent/ZA939609B/xx unknown
- 1993-12-22 CA CA002112196A patent/CA2112196A1/en not_active Abandoned
- 1993-12-22 SK SK1462-93A patent/SK146293A3/sk unknown
- 1993-12-23 CN CN93112787A patent/CN1093089A/zh active Pending
- 1993-12-23 PL PL93301623A patent/PL301623A1/xx unknown
- 1993-12-23 HR HR931517A patent/HRP931517A2/hr not_active Application Discontinuation
- 1993-12-23 BR BR9305213A patent/BR9305213A/pt not_active Application Discontinuation
- 1993-12-23 HU HU9303747A patent/HUT66141A/hu unknown
- 1993-12-23 NO NO934791A patent/NO934791L/no unknown
- 1993-12-23 TN TNTNSN93138A patent/TNSN93138A1/fr unknown
- 1993-12-24 MA MA23380A patent/MA23070A1/fr unknown
- 1993-12-24 SI SI9300685A patent/SI9300685A/sl unknown
- 1993-12-24 KR KR1019930029471A patent/KR940014406A/ko not_active Application Discontinuation
- 1993-12-24 OA OA60452A patent/OA09846A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI9300685A (en) | 1994-06-30 |
| FI935797A (fi) | 1994-06-25 |
| CA2112196A1 (en) | 1994-06-25 |
| ECSP930947A (es) | 1994-11-16 |
| UY23683A1 (es) | 1993-12-17 |
| CZ285693A3 (en) | 1994-07-13 |
| OA09846A (fr) | 1994-08-15 |
| BR9305213A (pt) | 1994-07-26 |
| MX9308061A (es) | 1994-06-30 |
| AU672056B2 (en) | 1996-09-19 |
| FI935797A0 (fi) | 1993-12-22 |
| EP0603755A3 (en) | 1994-09-28 |
| IL108134A0 (en) | 1994-04-12 |
| YU80593A (sh) | 1996-10-09 |
| PL301623A1 (en) | 1994-06-27 |
| CN1093089A (zh) | 1994-10-05 |
| NO934791D0 (no) | 1993-12-23 |
| HU9303747D0 (en) | 1994-04-28 |
| HRP931517A2 (en) | 1994-12-31 |
| NO934791L (no) | 1994-06-27 |
| MA23070A1 (fr) | 1994-07-01 |
| NZ250547A (en) | 1995-08-28 |
| KR940014406A (ko) | 1994-07-18 |
| TNSN93138A1 (fr) | 1994-03-17 |
| EP0603755A2 (de) | 1994-06-29 |
| ZA939609B (en) | 1994-08-11 |
| JPH06247974A (ja) | 1994-09-06 |
| DE4244069A1 (de) | 1994-06-30 |
| TW353662B (en) | 1999-03-01 |
| HUT66141A (en) | 1994-09-28 |
| AU5266793A (en) | 1994-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2229342T3 (es) | Sales de mesilato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona(=ziprasidona),su preparacion y uso como antagonista de dopamina d2. | |
| KR100632870B1 (ko) | 5-(2-(4-(1,2-벤즈이소티아졸-3-일)-1-피페라지닐)에틸)-6-클로로-1,3-디하이드로-2ｈ-인돌-2-온 하이드로클로라이드의 일수화물 | |
| KR101290893B1 (ko) | 피롤리디늄 염의 제조 방법 | |
| US6514986B2 (en) | Chiral fluoroquinolone arginine salt forms | |
| CA2550726A1 (en) | Methods of preparing aripiprazole crystalline forms | |
| RU2125571C1 (ru) | СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ | |
| AU2014336747A1 (en) | Crystal form of (r)-praziquantel and preparation method and application thereof | |
| SK302003A3 (en) | Stable gabapentin having pH within a controlled range | |
| EP1311506B1 (en) | Chiral fluoroquinolizinone arginine salt forms | |
| EP3831385B1 (en) | Mandelate salts of pirlindole enantiomers for use in medicine | |
| SK146293A3 (en) | Cefalosporine salts and method of their production | |
| MXPA02000033A (es) | Polimorfos de un diclorhidrato cristalino de azobiciclo (2, 2, 2)oct-3-ilamina y sus composiciones farmaceuticas. | |
| EP1181290B1 (en) | Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions | |
| FI62311B (fi) | Foerfarande foer framstaellning av kristallint natrium- och kaiumcefalexinmonohydrat | |
| AU704115B2 (en) | Zwitterionic forms of trovafloxacin | |
| CS195746B2 (en) | Process for preparing crystalline methanolate of natrium salt of cephamandole | |
| JPWO2002094829A1 (ja) | カルバペネム化合物 | |
| KR100696422B1 (ko) | 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린 | |
| US20040132743A1 (en) | Amorphous form of (-)-[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (levocetirizine dihydrochloride) | |
| JP3148235B2 (ja) | 抗菌性ペネム化合物 | |
| SK17342001A3 (sk) | Polymorfné formy kryštalického (2-benzhydryl-1-azabicyklo- [2.2.2]okt-3-yl)-(5-izopropyl-2-metoxybenzyl)amín-citrátu ako antagonistov receptora NK-1 | |
| CN1053611A (zh) | 新的β-内酰胺抗菌素的结晶盐酸盐及其制备方法 | |
| JPH0692970A (ja) | トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法 | |
| JPH0372480A (ja) | キサンチン誘導体及びそれらを有効成分とする気管支拡張剤 | |
| MXPA98009242A (en) | Salt mesylate trihydrate 5 - (- 2- (4- (1,2-benzoisotiazol-3-il) -1-piperazinil) ethyl) -6-chlorine-1,3-dihydro-2h-indol-2- |